Clinical Trial Update: Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating the central nervous system uptake of anti-CD8+ T cell minibodies for multiple sclerosis and progressive multifocal leukoenc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multifocal Leukoencephalopathy

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy | Phase 1 | Status: RECRUITING